Aura Biosciences
AURA
64 hedge funds and large institutions have $254M invested in Aura Biosciences in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 26 increasing their positions, 19 reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
37% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 19
8% more funds holding
Funds holding: 59 → 64 (+5)
0.35% more ownership
Funds ownership: 71.6% → 71.95% (+0.35%)
24% less capital invested
Capital invested by funds: $334M → $254M (-$80.1M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $9K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCMIC
Decheng Capital Management III (Cayman)
Grand Cayman,
Cayman Islands
|
+$9.36M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.78M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$962K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$769K |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$580K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$5.21M |
| 2 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$3.19M |
| 3 |
Morgan Stanley
New York
|
-$641K |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$639K |
| 5 |
Citigroup
New York
|
-$453K |
AURA Hedge Fund Activity: Q3 2023 in Review
64 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Aura Biosciences (AURA) for Q3 2023, worth a combined $254M — down 24% from $334M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new AURA positions and 1 closed out — a net gain of 5 holders — while 26 added to existing stakes and 19 trimmed.
The largest buyer was Decheng Capital Management III (Cayman), adding an estimated $9.36M. The largest seller was Bank of Montreal, exiting entirely with an estimated $5.21M sold.
- 64 institutional investors held Aura Biosciences (AURA) as of Q3 2023, up from 59 in Q2 2023.
- Funds reported $254M of Aura Biosciences stock for Q3 2023, down 24% quarter-over-quarter.
- 6 funds opened new Aura Biosciences positions in Q3 2023 and 1 closed out, a net change of +5 holders.
- The largest Aura Biosciences buyer in Q3 2023 was Decheng Capital Management III (Cayman), an estimated $9.36M added.
- The largest Aura Biosciences seller in Q3 2023 was Bank of Montreal, an estimated $5.21M sold.
Based on aggregated 13F filings for Q3 2023.